250 related articles for article (PubMed ID: 31530669)
1. Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies.
Gallichotte EN; Young EF; Baric TJ; Yount BL; Metz SW; Begley MC; de Silva AM; Baric RS
mBio; 2019 Sep; 10(5):. PubMed ID: 31530669
[TBL] [Abstract][Full Text] [Related]
2. Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy.
Tai W; Chen J; Zhao G; Geng Q; He L; Chen Y; Zhou Y; Li F; Du L
J Virol; 2019 Sep; 93(17):. PubMed ID: 31189716
[TBL] [Abstract][Full Text] [Related]
3. Dengue virus envelope protein domain III-elicited antibodies mediate cross-protection against Zika virus in a mouse model.
Zhou Y; Chen D; Yang L; Zou W; Duan Z; Zhang Y; Wen J
Virus Res; 2020 Mar; 278():197882. PubMed ID: 31981774
[TBL] [Abstract][Full Text] [Related]
4. Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection.
Premkumar L; Collins M; Graham S; Liou GA; Lopez CA; Jadi R; Balmaseda A; Brackbill JA; Dietze R; Camacho E; De Silva AD; Giuberti C; Dos Reis HL; Singh T; Heimsath H; Weiskopf D; Sette A; Osorio JE; Permar SR; Miley MJ; Lazear HM; Harris E; de Silva AM
J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263206
[TBL] [Abstract][Full Text] [Related]
5. A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies.
Graham SD; Tu HA; McElvany BD; Graham NR; Grinyo A; Davidson E; Doranz BJ; Diehl SA; de Silva AM; Markmann AJ
J Virol; 2021 Apr; 95(9):. PubMed ID: 33597214
[TBL] [Abstract][Full Text] [Related]
6. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody.
Esswein SR; Gristick HB; Jurado A; Peace A; Keeffe JR; Lee YE; Voll AV; Saeed M; Nussenzweig MC; Rice CM; Robbiani DF; MacDonald MR; Bjorkman PJ
Proc Natl Acad Sci U S A; 2020 May; 117(18):9865-9875. PubMed ID: 32321830
[TBL] [Abstract][Full Text] [Related]
8. ZIKV Envelope Domain-Specific Antibodies: Production, Purification and Characterization.
Akhras S; Herrlein ML; Elgner F; Holzhauser T; Hildt E
Viruses; 2019 Aug; 11(8):. PubMed ID: 31412626
[TBL] [Abstract][Full Text] [Related]
9. Yeast-produced subunit protein vaccine elicits broadly neutralizing antibodies that protect mice against Zika virus lethal infection.
Zhang W; Qu P; Li D; Zhang C; Liu Q; Zou G; Dupont-Rouzeyrol M; Lavillette D; Jin X; Yin F; Huang Z
Antiviral Res; 2019 Oct; 170():104578. PubMed ID: 31394119
[TBL] [Abstract][Full Text] [Related]
10. Probing Zika Virus Neutralization Determinants with Glycoprotein Mutants Bearing Linear Epitope Insertions.
Chambers MT; Schwarz MC; Sourisseau M; Gray ES; Evans MJ
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976678
[TBL] [Abstract][Full Text] [Related]
11. Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice.
Frei JC; Wirchnianski AS; Govero J; Vergnolle O; Dowd KA; Pierson TC; Kielian M; Girvin ME; Diamond MS; Lai JR
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976679
[TBL] [Abstract][Full Text] [Related]
12. Development of a neutralizing antibody targeting linear epitope of the envelope protein domain III of ZIKV.
Hu H; Liu R; Li Q; Wang J; Deng Q; Lu Y; Wu Q; Chen Z; Lu J
Virus Res; 2021 Dec; 306():198601. PubMed ID: 34678322
[TBL] [Abstract][Full Text] [Related]
13. Zika Virus-Like Particles Bearing a Covalent Dimer of Envelope Protein Protect Mice from Lethal Challenge.
De Lorenzo G; Tandavanitj R; Doig J; Setthapramote C; Poggianella M; Sanchez-Velazquez R; Scales HE; Edgar JM; Kohl A; Brewer J; Burrone OR; Patel AH
J Virol; 2020 Dec; 95(1):. PubMed ID: 33028720
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the immunogenicity of Zika glycan loop.
Henderson EA; Tam CC; Cheng LW; Ngono AE; Nguyen AV; Shresta S; McGee M; Padgett H; Grill LK; Martchenko Shilman M
Virol J; 2020 Mar; 17(1):43. PubMed ID: 32234060
[TBL] [Abstract][Full Text] [Related]
15. Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses.
Tai W; He L; Wang Y; Sun S; Zhao G; Luo C; Li P; Zhao H; Fremont DH; Li F; Jiang S; Zhou Y; Du L
Emerg Microbes Infect; 2018 Jan; 7(1):7. PubMed ID: 29362446
[TBL] [Abstract][Full Text] [Related]
16. Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.
Hsieh SC; Tsai WY; Tsai JJ; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
J Virol; 2021 Sep; 95(19):e0061921. PubMed ID: 34232731
[TBL] [Abstract][Full Text] [Related]
17. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
[TBL] [Abstract][Full Text] [Related]
18. Human Monoclonal Antibodies Potently Neutralize Zika Virus and Select for Escape Mutations on the Lateral Ridge of the Envelope Protein.
Bailey MJ; Broecker F; Freyn AW; Choi A; Brown JA; Fedorova N; Simon V; Lim JK; Evans MJ; García-Sastre A; Palese P; Tan GS
J Virol; 2019 Jul; 93(14):. PubMed ID: 31043537
[TBL] [Abstract][Full Text] [Related]
19. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
[TBL] [Abstract][Full Text] [Related]
20. Human antibody response to Zika targets type-specific quaternary structure epitopes.
Collins MH; Tu HA; Gimblet-Ochieng C; Liou GA; Jadi RS; Metz SW; Thomas A; McElvany BD; Davidson E; Doranz BJ; Reyes Y; Bowman NM; Becker-Dreps S; Bucardo F; Lazear HM; Diehl SA; de Silva AM
JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
